Issue 19, 2024

Highly cytotoxic Cu(ii) terpyridine complexes as chemotherapeutic agents

Abstract

Cancer is considered as the biggest medicinal challenge worldwide. During a typical treatment, the tumorous tissue is removed in a surgical procedure and the patient further treated by chemotherapy. One of the most frequently applied drugs are platinum complexes. Despite their clinical success, these compounds are associated with severe side effects and low therapeutic efficiency. To overcome these limitations, herein, the synthesis and biological evaluation of Cu(II) terpyridine complexes as chemotherapeutic drug candidates is suggested. The compounds were found to be highly cytotoxic in the nanomolar range against various cancer cell lines. Mechanistic insights revealed that the compounds primarily accumulated in the cytoplasm and generated reactive oxygen species in this organelle, triggering cell death by apoptosis. Based on their high therapeutic effect, these metal complexes could serve as a starting point for further drug development.

Graphical abstract: Highly cytotoxic Cu(ii) terpyridine complexes as chemotherapeutic agents

Supplementary files

Article information

Article type
Paper
Submitted
13 Mar 2024
Accepted
17 Apr 2024
First published
19 Apr 2024
This article is Open Access
Creative Commons BY license

Dalton Trans., 2024,53, 8223-8228

Highly cytotoxic Cu(II) terpyridine complexes as chemotherapeutic agents

K. Ni, N. Montesdeoca and J. Karges, Dalton Trans., 2024, 53, 8223 DOI: 10.1039/D4DT00759J

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements